Anika Therapeutics, Inc. Restructuring Charges
Anika Therapeutics, Inc. (ANIK) reported Restructuring Charges of $2.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-07-29
- Anika Therapeutics, Inc. restructuring charges for the quarter ending 2026-06-30 was $532.00K.
- Anika Therapeutics, Inc. restructuring charges for the quarter ending 2026-03-31 was $1.59M.
- Anika Therapeutics, Inc. restructuring charges for the quarter ending 2014-03-31 was -$135.61K.
- Anika Therapeutics, Inc. restructuring charges for the quarter ending 2013-12-31 was $156.03K.
- Anika Therapeutics, Inc. restructuring charges for fiscal 2013 was -$286.84K, a 111.30% decline from fiscal 2012.
- Anika Therapeutics, Inc. restructuring charges for fiscal 2012 was $2.54M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $532.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $2.12M 10-Q · filed 2026-07-29 | |||
| 2026-03-31 | $1.59M 10-Q · filed 2026-04-30 | ||||
| 2014-03-31 | -$135.61K 10-Q · filed 2014-05-05 | $20.42K derived: sum of 2 quarters · filed 2015-03-13 | -$175.66K derived: sum of 3 quarters · filed 2015-03-13 | -$64.49K derived: sum of 4 quarters · filed 2015-03-13 | |
| 2013-12-31 | $156.03K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | -$40.06K derived: sum of 2 quarters · filed 2015-03-13 | $71.12K derived: sum of 3 quarters · filed 2015-03-13 | -$286.84K 10-K · filed 2015-03-13 | |
| 2013-09-30 | -$196.08K 10-Q · filed 2013-11-05 | -$84.91K derived: sum of 2 quarters · filed 2013-11-05 | -$442.87K 10-Q · filed 2013-11-05 | ||
| 2013-06-30 | $111.18K 10-Q · filed 2013-08-06 | $246.78K 10-Q · filed 2013-08-06 | |||
| 2013-03-31 | -$135.61K 10-Q · filed 2014-05-05 | $135.61K 10-Q · filed 2013-05-06 | |||
| 2012-12-31 | $2.54M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |